Table 3 Multivariate analysis with logistic regression in the MRI imaging features

20% of Ki-67 cutoff

 Nonperipheral washout

-0.794

0.285

0.452 (0.105–1.938)

 Mosaic architecture

0.796

0.077

2.216 (0.918–5.350)

 Rim APHE

19.08

0.998

1.93 × 10⁸ (0)

 Targetoid restriction

19.439

0.998

2.77 × 10⁸ (0)

 Peritumoral enhancement

18.844

0.998

1.53 × 10⁸ (0)

30% of Ki-67 cutoff

 Nodule in nodule

-0.269

0.734

0.764 (0.162–3.599)

 Mosaic architecture

0.897

0.251

2.453 (0.531–11.339)

 Corona enhancement

0.826

0.505

2.285 (0.201–25.908)

 Rim APHE

20.436

0.998

7.5 × 10⁸ (0)

 Delayed central enhancement

19.197

0.999

2.17 × 10⁸ (0)

 Targetoid restriction

0.082

0.935

1.086 (0.148–7.979)

 Satellite nodules

0.207

0.680

1.23 (0.459–3.294)

 Portal and hepatic vein tumor thrombus

0.657

0.307

1.93 (0.547–6.805)

 Peritumoral enhancement

0.703

0.569

2.02 (0.179–22.736)

50% of Ki-67 cutoff

 Size (≥ 5 cm)

-0.852

0.280

0.427(0.091–2.003)

 Nodule in nodule

0.862

0.365

2.367(0.367–15.28)

 Mosaic architecture

1.706

0.045^*

5.507(1.036–29.271)

 Blood products in mass

0.149

0.810

1.16(0.346–3.895)

 Mild to moderate T2 hyperintensity

-21.537

0.999

0(0)

 Corona enhancement

2.195

0.078

8.983(0.785–102.793)

 Targetoid HBP

-1.304

0.035^*

0.271(0.081–0.915)

 Infiltrated appearance

1.141

0.039^*

3.129(1.058–9.258)

 Portal and hepatic vein tumor thrombus

0.108

0.862

1.114(0.330–3.764)

 Peritumoral enhancement

0.309

0.776

1.362(0.163–11.381)